Cardiovascular considerations also apply, as NSAIDs have been associated with increased risk of heart attack and stroke, particularly with long-term use
In 2008, Rimonabant (also known as SR141716) was withdrawn from the market worldwide after being approved in 2006 due to serious psychiatric side effects that outweighed its benefits, including suicide
By partnering with a pharmacy benefits provider such as Excellus BCBS, employers can better control costs, protect their bottom line and ensure their workforce receives the appropriate care
Specific Populations No clinically significant differences in semaglutide pharmacokinetics were observed based on age (18 years old), sex, race (White, Asian or Black or African American), ethnicity, body weight (40 to 188 kg), upper GI disease (i.e., chronic gastritis and/or gastroesophageal reflux disease), hepatic impairment (i.e., mild, moderate, severe based on the Child-Pugh system) and renal impairment (i.e., mild, moderate, severe, end staged renal disease)
The identification of several genes involved in these processes sets the stage for disease development and maintenance